Plan a pilot

Plan one blinded MLTox pilot

Tell us the decision, representative input set, and evidence your team needs to act. Please don't include confidential molecular structures or patient information.

What happens next

We identify the product and scientific decision owner.
We confirm whether the use is inside the current product boundary.
We define the evidence, comparison, and exit criteria for an evaluation.
Enterprise review can run in parallel when production use is the goal.

First name

Last name

Work email

Organization

Role or title

Organization type

Product interest

Development stage

Decision objective and timing

Deployment interest

Evaluation constraints

I confirm that this request contains no confidential molecular, patient, credential, or regulated data.